TrialEuropean journal of pediatrics2018

A 26-week, randomized trial of insulin detemir versus NPH insulin in children and adolescents with type 2 diabetes (iDEAt2).

Mark D Wheeler et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.